Fact CheckerSign in

NCT05783271Recruiting

Validity of Parametric MRI Using VIRADS

Validity of Parametric MRI Using VIRAD Scoring in the Diagnosis of Cancer Bladder

Source: ClinicalTrials.gov · Last updated 2 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Our aim in this prospective study is to evaluate the validity of the non-contrast biparametric MRI (bp-MRI), including T2-WI and DWI sequences, and the availability of an alternative to the mp-MRI, for the muscle invasiveness assessment of bladder cancer using VIRAD scoring in both techniques.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
58 (estimated)
First submitted
2 Mar 2023
Start date
Dec 2025
Primary completion date
Jul 2026
Lead sponsor
Assiut University
NCT number
NCT05783271

What you commit to

  • Study type: Interventional
  • Planned participants: 58
  • From Dec 2025 to the primary completion date, Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • patient with high renal chemistry. Patient with contraindications to MRI as pacemaker and cochlear implants.

Other

  • \-

Who the study is looking for

  • 58 cases of patients who suspected to have cancer urinary bladder by clinical, histopathological examination and radiological imaging.
  • All age groups . Both sex

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Assuit university
Coordinator of this site? Confirm its status		AsyutEgyptRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.